These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 8121073
1. [The estimation of effective renal plasma flow (ERPF) based on two compartment analysis using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3)]. Ha-Kawa SK, Suga Y, Satou H, Tanaka Y. Kaku Igaku; 1994 Feb; 31(2):175-81. PubMed ID: 8121073 [Abstract] [Full Text] [Related]
2. Correlation of the ERPF with the extraction fraction values of technetium-99m mercaptoacetyltriglycine. Chotipanich C, Hickeson M, Khan J, Beauchemin D, Canning D, Charron M. J Med Assoc Thai; 2006 Sep; 89(9):1479-86. PubMed ID: 17100388 [Abstract] [Full Text] [Related]
4. [Clinical evaluation of 99mTc-MAG3 as a radiotracer to assess the function of transplanted kidney: comparison with 123I-OIH]. Yamamoto K, Takahashi N, Sugimoto K, Yoshida M, Hayashi N, Ishii Y, Nishibuchi S, Muranaka K, Okada K, Miyazaki M. Nihon Igaku Hoshasen Gakkai Zasshi; 1995 May; 55(6):409-13. PubMed ID: 7617467 [Abstract] [Full Text] [Related]
13. A comparison of single plasma sample methods to estimate renal clearance using 99mTc-ethylenedicysteine and 99mTc-mercaptoacetyltriglycine. Sohaib M, Rafique A, Saeed S, Afshan A. Clin Physiol Funct Imaging; 2013 Sep; 33(5):353-8. PubMed ID: 23701132 [Abstract] [Full Text] [Related]
14. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine. Taylor A, Ziffer JA, Steves A, Eshima D, Delaney VB, Welchel JD. Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734 [Abstract] [Full Text] [Related]
15. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function]. Di Lorenzo I, Stiglich F, Barbonetti C, Bonomo F, Maspero S, Paini S, Bottinelli G. Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030 [Abstract] [Full Text] [Related]
16. [Phase 3 clinical study of 99mTc-MAG3 injectable, a dynamic renal imaging agent--comparison with 123I-OIH and 99mTc-DTPA]. Torizuka K, Ishibashi A, Ikekubo K, Yamamoto K, Nishibuchi S. Kaku Igaku; 1994 Feb; 31(2):183-98. PubMed ID: 8121074 [Abstract] [Full Text] [Related]
17. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method]. Hashimoto T, Matsumoto K, Ishibashi R, Iwasaki R, Sanmiya T, Hashimoto J, Kunieda E, Nakamura K, Kubo A. Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099 [Abstract] [Full Text] [Related]
18. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA]. Lepej J, Marosová A, Kliment J, Buchanec J, Svitác J, Klisenbauer L. Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424 [Abstract] [Full Text] [Related]